Logo image of ABCM

ABCAM PLC-SPON ADR (ABCM) Stock Overview

USA - NASDAQ:ABCM - US0003802040 - ADR

23.99 USD
+0.01 (+0.04%)
Last: 12/5/2023, 8:00:00 PM
23.99 USD
0 (0%)
After Hours: 12/5/2023, 8:00:00 PM

ABCM Key Statistics, Chart & Performance

Key Statistics
52 Week High25.32
52 Week Low12.48
Market Cap5.49B
Shares229.05M
Float209.14M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.54
PE44.43
Fwd PE49.32
Earnings (Next)N/A N/A
IPO11-03 2005-11-03
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


ABCM short term performance overview.The bars show the price performance of ABCM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40

ABCM long term performance overview.The bars show the price performance of ABCM in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40 50

The current stock price of ABCM is 23.99 USD. In the past month the price increased by 3.05%. In the past year, price increased by 54.57%.

ABCAM PLC-SPON ADR / ABCM Daily stock chart

ABCM Latest News, Press Relases and Analysis

ABCM Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.64 404.77B
AMGN AMGEN INC 13.47 158.20B
GILD GILEAD SCIENCES INC 15.31 147.01B
VRTX VERTEX PHARMACEUTICALS INC 24.33 105.69B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 61.52B
REGN REGENERON PHARMACEUTICALS 12.55 60.69B
ARGX ARGENX SE - ADR 87.7 49.75B
ONC BEONE MEDICINES LTD-ADR 5.19 35.25B
INSM INSMED INC N/A 34.11B
BNTX BIONTECH SE-ADR N/A 24.67B
NTRA NATERA INC N/A 23.72B
BIIB BIOGEN INC 9.08 21.30B

About ABCM

Company Profile

ABCM logo image Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. The company is headquartered in Cambridge, Cambridgeshire and currently employs 1,750 full-time employees. The company went IPO on 2005-11-03. The firm is engaged in the identification, development and distribution of biological reagents. The Company’s products are used by various researchers worldwide to study biological pathways critical for scientific research, diagnostics and drug discovery. Its products can be grouped into two categories: research use only (RUO) proteomic tools and antibodies for clinical application. RUO products include protein binding reagents, such as antibodies and immunoassays, and related reagents. Its RUO products are used to detect, quantify, visualize and modify proteins in scientific research experiments, serving as vital tools to enable its customers to develop insights about targets and biological pathways of interest. Antibodies are a core component of many in vitro diagnostic assays and can also be used as therapeutic agents to treat various diseases, including cancer.

Company Info

ABCAM PLC-SPON ADR

Discovery Drive, Cambridge Biomedical Campus, Hills Road

Cambridge CAMBRIDGESHIRE CB2 0AX GB

CEO: Alan Hirzel

Employees: 1750

ABCM Company Website

Phone: 441223696000.0

ABCAM PLC-SPON ADR / ABCM FAQ

What is the stock price of ABCAM PLC-SPON ADR today?

The current stock price of ABCM is 23.99 USD. The price increased by 0.04% in the last trading session.


What is the ticker symbol for ABCAM PLC-SPON ADR stock?

The exchange symbol of ABCAM PLC-SPON ADR is ABCM and it is listed on the Nasdaq exchange.


On which exchange is ABCM stock listed?

ABCM stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ABCAM PLC-SPON ADR stock?

15 analysts have analysed ABCM and the average price target is 20.23 USD. This implies a price decrease of -15.68% is expected in the next year compared to the current price of 23.99. Check the ABCAM PLC-SPON ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ABCAM PLC-SPON ADR worth?

ABCAM PLC-SPON ADR (ABCM) has a market capitalization of 5.49B USD. This makes ABCM a Mid Cap stock.


How many employees does ABCAM PLC-SPON ADR have?

ABCAM PLC-SPON ADR (ABCM) currently has 1750 employees.


What are the support and resistance levels for ABCAM PLC-SPON ADR (ABCM) stock?

ABCAM PLC-SPON ADR (ABCM) has a support level at 23.96 and a resistance level at 24.47. Check the full technical report for a detailed analysis of ABCM support and resistance levels.


Is ABCAM PLC-SPON ADR (ABCM) expected to grow?

The Revenue of ABCAM PLC-SPON ADR (ABCM) is expected to grow by 24.37% in the next year. Check the estimates tab for more information on the ABCM EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ABCAM PLC-SPON ADR (ABCM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ABCAM PLC-SPON ADR (ABCM) stock pay dividends?

ABCM does not pay a dividend.


What is the Price/Earnings (PE) ratio of ABCAM PLC-SPON ADR (ABCM)?

The PE ratio for ABCAM PLC-SPON ADR (ABCM) is 44.43. This is based on the reported non-GAAP earnings per share of 0.54 and the current share price of 23.99 USD. Check the full fundamental report for a full analysis of the valuation metrics for ABCM.


ABCM Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to ABCM. When comparing the yearly performance of all stocks, ABCM is one of the better performing stocks in the market, outperforming 89.33% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ABCM Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to ABCM. ABCM scores excellent on profitability, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ABCM Financial Highlights

Over the last trailing twelve months ABCM reported a non-GAAP Earnings per Share(EPS) of 0.54. The EPS increased by 402.64% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.94%
ROA 0.64%
ROE 0.93%
Debt/Equity 0.3
Chartmill High Growth Momentum
EPS Q2Q%191.67%
Sales Q2Q%23.3%
EPS 1Y (TTM)402.64%
Revenue 1Y (TTM)17.7%

ABCM Forecast & Estimates

15 analysts have analysed ABCM and the average price target is 20.23 USD. This implies a price decrease of -15.68% is expected in the next year compared to the current price of 23.99.

For the next year, analysts expect an EPS growth of 125.95% and a revenue growth 24.37% for ABCM


Analysts
Analysts80
Price Target20.23 (-15.67%)
EPS Next Y125.95%
Revenue Next Year24.37%

ABCM Ownership

Ownership
Inst Owners1.79%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A